Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility

References

• Jabbour EJ, Faderl S, Kantarjian HM. Adult acute lymphoblastic leukemia. Mayo Clin Proc. 2005;80(11):1517–1527.
   PubMed Web of Science ®Google Scholar
• Esparza SD, Sakamoto KM. Topics in pediatric leukemia–acute lymphoblastic leukemia. MedGenMed. 2005;7(1):23.
   PubMedGoogle Scholar
• Pulte D, Jansen L, Gondos A, et al. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One. 2014;9(1):e85554.
   PubMed Web of Science ®Google Scholar
• Larson RA, Dodge RK, Burns CP, et al. A Five-Drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood. 1995;85(8):2025–2037.
   PubMed Web of Science ®Google Scholar
• Gupta R, Othman T, Uche A, et al. Characteristics and trends of adult acute lymphoblastic leukemia in a large, public Safety-Net hospital. Clin Lymphoma Myeloma Leuk. 2020;20(6):e320–e327.
   PubMed Web of Science ®Google Scholar
• Karuturi MS, Yorio JT, Titus A, et al. Improving the care of acute lymphocytic leukemia (ALL) at a large county hospital. J Clin Oncol. 2013;31(31_suppl):213–213.
   Web of Science ®Google Scholar
• Bilimoria KY, Stewart AK, Winchester DP, et al. The national cancer data base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683–690.
   PubMed Web of Science ®Google Scholar
• Winchester DP, Stewart AK, Bura C, et al. The national cancer data base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85(1):1–3.
   PubMed Web of Science ®Google Scholar
• Little R, Rubin D. Statistical analysis with missing data. 3rd ed. Vol. 793. Wiley; 2019. ISBN: 9780470526798.
   Google Scholar
• Wolfson JA, Sun CL, Wyatt LP, et al. Impact of care at comprehensive cancer centers on outcome: results from a population-based study. Cancer. 2015;121(21):3885–3893.
   PubMed Web of Science ®Google Scholar
• Lou Y, Dholaria B, Soyano A, et al. Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers. Cancer Med. 2018;7(10):4932–4942.
   PubMed Web of Science ®Google Scholar
• Bhatt VR, Shostrom V, Giri S, et al. Early mortality and overall survival of acute myeloid leukemia based on facility type. Am J Hematol. 2017;92(8):764–771.
   PubMed Web of Science ®Google Scholar
• Patel MI, Ma Y, Mitchell BS, et al. Understanding disparities in leukemia: a national study. Cancer Causes Control. 2012;23(11):1831–1837.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang Y, Ma S. Racial differences in four leukemia subtypes: Comprehensive descriptive epidemiology. Sci Rep. 2018;8(1):548.
   PubMedGoogle Scholar
• Mitchell AP, Kinlaw AC, Peacock-Hinton S, et al. Use of high-cost cancer treatments in academic and nonacademic practice. Oncologist. 2020;25(1):46–54.
   PubMed Web of Science ®Google Scholar
• Perry AM, Brunner AM, Zou T, et al. Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: a population-based study. Cancer. 2017;123(13):2561–2569.
   PubMed Web of Science ®Google Scholar
• Krakora R, Shih W, Popli P, et al. Impact of insurance status on survival outcomes in adults with acute lymphoblastic leukemia (ALL): a single-center experience. Clin Lymphoma Myeloma Leuk. 2020;20(11):e890–e896.
   PubMed Web of Science ®Google Scholar
• Carey RM, Fathy R, Shah RR, et al. Association of type of treatment facility with overall survival after a diagnosis of head and neck cancer. JAMA Netw Open. 2020;3(1):e1919697.
   PubMed Web of Science ®Google Scholar
• Uhlig J, Sellers CM, Khan SA, et al. Hepatocellular carcinoma: Impact of academic setting and hospital volume on patient survival. Surg Oncol. 2019;31:111–118.
   PubMed Web of Science ®Google Scholar
• Master S, Mansour R, Devarakonda SS, et al. Predictors of survival in acute myeloid leukemia by treatment modality. Anticancer Res. 2016;36(4):1719–1727.
   PubMed Web of Science ®Google Scholar
• Manikkam Umakanthan J, Chen B, Gundabolu K, et al. Socioeconomic factors associated with overall survival (OS) in adults with acute lymphoblastic leukemia (ALL). Blood. 2017;130(Supplement 1):3431–3431.
   Google Scholar
• Mahal BA, Chen YW, Muralidhar V, et al. National sociodemographic disparities in the treatment of high-risk prostate cancer: do academic cancer centers perform better than community cancer centers? Cancer. 2016;122(21):3371–3377.
   PubMed Web of Science ®Google Scholar
• Ambroggi M, Biasini C, Del Giovane C, et al. Distance as a barrier to cancer diagnosis and treatment: review of the Literature. Oncologist. 2015;20(12):1378–1385.
   PubMed Web of Science ®Google Scholar
• Vetterlein MW, Löppenberg B, Karabon P, et al. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Cancer. 2017;123(17):3241–3252.
   PubMed Web of Science ®Google Scholar
• Bloom M, Markovitz S, Silverman S, et al. Ten trends transforming cancer care and their effects on space planning for academic medical centers. Herd. 2015;8(2):85–94.
   PubMedGoogle Scholar
• Fujiwara RJ, Judson BL, Yarbrough WG, et al. Treatment delays in oral cavity squamous cell carcinoma and association with survival. Head Neck. 2017;39(4):639–646.
   PubMed Web of Science ®Google Scholar
• Samson P, Patel A, Garrett T, et al. Effects of delayed surgical resection on Short-Term and Long-Term outcomes in clinical stage I Non-Small cell lung cancer. Ann Thorac Surg. 2015;99(6):1906–1912.
   PubMed Web of Science ®Google Scholar
• Cone EB, Marchese M, Paciotti M, et al. Assessment of time-to-Treatment initiation and survival in a cohort of patients with common cancers. JAMA Netw Open. 2020;3(12):e2030072.
   PubMed Web of Science ®Google Scholar
• Mallin K, Browner A, Palis B, et al. Incident cases captured in the national cancer database compared with those in U.S. Population based Central cancer registries in 2012-2014. Ann Surg Oncol. 2019;26(6):1604–1612.
   PubMed Web of Science ®Google Scholar
• Algan O, Algan SM, Campbell JE. Racial and regional referral patterns to a CoC accredited facility for cancer management. Int J Radiat Oncol Biol Phys. 2016;96(2):E406. 2016/10/01/
   PubMed Web of Science ®Google Scholar
• Loberiza FR Jr, Cannon AJ, Weisenburger DD, et al. Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study. J Clin Oncol. 2009;27(32):5376–5382.
   PubMed Web of Science ®Google Scholar
• Thomas DA, O'Brien S, Faderl S, et al. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. J Clin Oncol. 2010;28(24):3880–3889.
   PubMed Web of Science ®Google Scholar
• Master S, Koshy N, Mansour R, et al. Effect of stem cell transplant on survival in adult patients with acute lymphoblastic leukemia: NCDB analysis. Anticancer Res. 2019;39(4):1899–1906.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi K, Kako S, Shigematsu A, et al. Comparison of cyclophosphamide combined with total body irradiation, oral busulfan, or intravenous busulfan for allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2016;22(12):2194–2200.
   PubMed Web of Science ®Google Scholar
• Kuo W-H, Chen Y-H, Tsai C-H, et al. Outcome of acute leukemia patients with Central nervous system (CNS) involvement treated with total body or CNS irradiation before transplantation. Ther Radiol Oncol. 2018;2:29–29.
   Google Scholar
• Amin S, Baine M, Meza J, et al. The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type. BMC Cancer. 2021;21(1):387.
   PubMed Web of Science ®Google Scholar
• David JM, Ho AS, Luu M, et al. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. Cancer. 2017;123(20):3933–3942.
   PubMed Web of Science ®Google Scholar
• Ferro RA, Shostrom V, Vose JM, et al. Overall survival (OS) of acute lymphoblastic leukemia (ALL) is better when initial therapy is administered in academic hospitals (AH) versus Non-Academic hospitals (NAH): a retrospective analysis of the national cancer data base (NCDB). Blood. 2015;126(23):268–268.
   Web of Science ®Google Scholar
• Gill A, Gosain R, Bhandari S, et al. “Lost to follow-up” among adult cancer survivors. Am J Clin Oncol. 2018;41(10):1024–1027.
   PubMed Web of Science ®Google Scholar
• Wolfson J, Sun CL, Wyatt L, et al. Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia: Impact of care at specialized cancer centers on survival outcome. Cancer Epidemiol Biomarkers Prev. 2017;26(3):312–320.
   PubMed Web of Science ®Google Scholar
• Bencomo-Alvarez AE, Rubio AJ, Gonzalez MA, et al. Blood cancer health disparities in the United States hispanic population. Cold Spring Harb Mol Case Stud. 2021;7(2):a005967. doi: https://doi.org/10.1101/mcs.a005967.
   Google Scholar